Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus.

about

Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus.

Item

http://www.wikidata.org/entity/Q46981976

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Renoprotective Effect of Dipep ...... with Type 2 Diabetes Mellitus.

@en

Renoprotective Effect of Dipep ...... with Type 2 Diabetes Mellitus.

@nl

type

Item

label

Renoprotective Effect of Dipep ...... with Type 2 Diabetes Mellitus.

@en

Renoprotective Effect of Dipep ...... with Type 2 Diabetes Mellitus.

@nl

prefLabel

Renoprotective Effect of Dipep ...... with Type 2 Diabetes Mellitus.

@en

Renoprotective Effect of Dipep ...... with Type 2 Diabetes Mellitus.

@nl

P1476

Renoprotective Effect of Dipep ...... with Type 2 Diabetes Mellitus

@en

P2093

Aki Yoshida

http://www.w3.org/2001/XMLSchema#string

Chitoshi Goto

http://www.w3.org/2001/XMLSchema#string

Hiroki Esaki

http://www.w3.org/2001/XMLSchema#string

Hitomi Teramachi

http://www.w3.org/2001/XMLSchema#string

Ikuto Sugita

http://www.w3.org/2001/XMLSchema#string

Kosuke Saito

http://www.w3.org/2001/XMLSchema#string

Masumi Yamamura

http://www.w3.org/2001/XMLSchema#string

Satoshi Aoyama

http://www.w3.org/2001/XMLSchema#string

Takashi Mizui

http://www.w3.org/2001/XMLSchema#string

Yuki Ohno

http://www.w3.org/2001/XMLSchema#string

P2860

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

Risk factors for chronic kidney disease: an update

Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies

Cardiovascular effects of incretin therapy in diabetes care.

Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney.

P304

835

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2017.00835

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tomoya Tachi

Y Noguchi

M Yasuda

P577

2017-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29187821

http://www.w3.org/2001/XMLSchema#string

P932

5694778

http://www.w3.org/2001/XMLSchema#string